1
|
Marycz K, Kowalczuk A, Turlej E, Zachanowicz E, Tomaszewska A, Kulpa-Greszta M, Kępska M, Steczkiewicz Z, Pązik R. Impact of Polyrhodanine Manganese Ferrite Binary Nanohybrids (PRHD@MnFe 2O 4) on Osteoblasts and Osteoclasts Activities-A Key Factor in Osteoporosis Treatment. MATERIALS 2022; 15:ma15113990. [PMID: 35683288 PMCID: PMC9181943 DOI: 10.3390/ma15113990] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/22/2022] [Revised: 05/30/2022] [Accepted: 05/31/2022] [Indexed: 01/01/2023]
Abstract
Osteoporosis is characterized by the reduction of bone mineral density and the weakness of the bone strength leading to fractures. Searching for new compounds that stimulate bone activity and their ability to reconstruct seems to be a promising tool in osteoporosis treatment. Here, we performed analyses comparing the impact of polyrhodanine (PRHD) and its derivatives on the viability (anti-proliferative tests), morphology and mitochondrial network (confocal microscopy) towards pre-osteoblasts (MC3T3-E1 cell line) and osteoclasts (4B12 cell line). Moreover, we assessed the expression of genes associated with the apoptosis, inflammation and osteogenic differentiation by qPCR technique. Our results clearly demonstrated that PRHD and its modification at ratio 10/90 significantly improves the pre-osteoblast’s proliferative abilities, while reducing osteoclast function. The observed effects were strongly correlated with the cytoskeleton and mitochondrial network development and arrangement. Additionally, the expression profile of genes revealed enhanced apoptosis of osteoclasts in the case of PRHD and its modification at ratio 10/90. Moreover, in this case we also observed strong anti-inflammatory properties demonstrated by decreased expression of Il1b, Tnfa and Tgfb in pre-osteoblasts and osteoclasts. On the other hand, enhanced expression of the markers associated with bone remodeling, namely, osteopontin (OPN), osteocalcin (OCL) and alkaline phosphatase (ALP), seem to confirm the role of PRHD@MnFe2O4 in the promotion of differentiation of pre-osteoblasts through the ALP-OPN-OCL axis. Based on these observations, PRHD@MnFe2O4 could be a potential agent in osteoporosis treatment in future, however, further studies are still required.
Collapse
Affiliation(s)
- Krzysztof Marycz
- Department of Experimental Biology, Wroclaw University of Environmental and Life Science, Norwida 27, 50-375 Wroclaw, Poland; (E.T.); (M.K.); (Z.S.)
- National Medicines Institute (NIL), Chelmska 30/34, 00-725 Warszawa, Poland;
- Correspondence:
| | - Anna Kowalczuk
- National Medicines Institute (NIL), Chelmska 30/34, 00-725 Warszawa, Poland;
| | - Eliza Turlej
- Department of Experimental Biology, Wroclaw University of Environmental and Life Science, Norwida 27, 50-375 Wroclaw, Poland; (E.T.); (M.K.); (Z.S.)
| | - Emilia Zachanowicz
- Polymer Engineering and Technology Division, Wroclaw University of Technology, Wyspianskiego 27, 50-370 Wroclaw, Poland;
| | - Anna Tomaszewska
- Department of Biotechnology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland; (A.T.); (M.K.-G.); (R.P.)
| | - Magdalena Kulpa-Greszta
- Department of Biotechnology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland; (A.T.); (M.K.-G.); (R.P.)
- Faculty of Chemistry, Rzeszow University of Technology, Powstancow Warszawy 12, 35-959 Rzeszow, Poland
| | - Martyna Kępska
- Department of Experimental Biology, Wroclaw University of Environmental and Life Science, Norwida 27, 50-375 Wroclaw, Poland; (E.T.); (M.K.); (Z.S.)
| | - Zofia Steczkiewicz
- Department of Experimental Biology, Wroclaw University of Environmental and Life Science, Norwida 27, 50-375 Wroclaw, Poland; (E.T.); (M.K.); (Z.S.)
| | - Robert Pązik
- Department of Biotechnology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland; (A.T.); (M.K.-G.); (R.P.)
| |
Collapse
|
2
|
Marycz K, Śmieszek A, Kornicka-Garbowska K, Pielok A, Janeczek M, Lipińska A, Nikodem A, Filipiak J, Sobierajska P, Nedelec JM, Wiglusz RJ. Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2. Int J Nanomedicine 2021; 16:6049-6065. [PMID: 34511905 PMCID: PMC8418301 DOI: 10.2147/ijn.s316240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Accepted: 07/28/2021] [Indexed: 11/25/2022] Open
Abstract
Purpose Healing of osteoporotic defects is challenging and requires innovative approaches to elicit molecular mechanisms promoting osteoblasts-osteoclasts coupling and bone homeostasis. Methods Cytocompatibility and biocompatibility of previously characterised nanocomposites, i.e Ca5(PO4)3OH/Fe3O4 (later called nHAp/IO) functionalised with microRNAs (nHAp/IO@miR-21/124) was tested. In vitro studies were performed using a direct co-culture system of MC3T3-E1 pre-osteoblast and 4B12 pre-osteoclasts. The analysis included determination of nanocomposite influence on cultures morphology (confocal imaging), viability and metabolic activity (Alamar Blue assay). Pro-osteogenic signals were identified at mRNA, miRNA and protein level with RT-qPCR, Western blotting and immunocytochemistry. Biocompatibility of biomaterials was tested using bilateral cranial defect performed on a senescence-accelerated mouse model, ie SAM/P6 and Balb/c. The effect of biomaterial on the process of bone healing was monitored using microcomputed tomography. Results The nanocomposites promoted survival and metabolism of bone cells, as well as enhanced functional differentiation of pre-osteoblasts MC3T3-E1 in co-cultures with pre-osteoclasts. Differentiation of MC3T3-E1 driven by nHAp/IO@miR-21/124 nanocomposite was manifested by improved extracellular matrix differentiation and up-regulation of pro-osteogenic transcripts, ie late osteogenesis markers. The nanocomposite triggered bone healing in a cranial defect model in SAM/P6 mice and was replaced by functional bone in Balb/c mice. Conclusion This study demonstrates that the novel nanocomposite nHAp/IO can serve as a platform for therapeutic miRNA delivery. Obtained nanocomposite elicit pro-osteogenic signals, decreasing osteoclasts differentiation, simultaneously improving osteoblasts metabolism and their transition toward pre-osteocytes and bone mineralisation. The proposed scaffold can be an effective interface for in situ regeneration of osteoporotic bone, especially in elderly patients.
Collapse
Affiliation(s)
- Krzysztof Marycz
- Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Wroclaw, 50-375, Poland.,International Institute of Translational Medicine, Malin, 55-124, Poland
| | - Agnieszka Śmieszek
- Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Wroclaw, 50-375, Poland
| | - Katarzyna Kornicka-Garbowska
- Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Wroclaw, 50-375, Poland.,International Institute of Translational Medicine, Malin, 55-124, Poland
| | - Ariadna Pielok
- Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Wroclaw, 50-375, Poland
| | - Maciej Janeczek
- Department of Biostructure and Animal Physiology, Wroclaw University of and Life Sciences, Wroclaw, 51-631, Poland
| | - Anna Lipińska
- Department of Biostructure and Animal Physiology, Wroclaw University of and Life Sciences, Wroclaw, 51-631, Poland
| | - Anna Nikodem
- Department of Mechanics, Materials and Biomedical Engineering, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, 50-370 Wrocław, Poland
| | - Jarosław Filipiak
- Department of Mechanics, Materials and Biomedical Engineering, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, 50-370 Wrocław, Poland
| | - Paulina Sobierajska
- Institute of Low Temperature and Structure Research, Polish Academy of Sciences, Okolna 2, 50-422 Wroclaw, Poland
| | - Jean-Marie Nedelec
- Universite Clermont Auvergne, Clermont Auvergne INP, CNRS, ICCF, Clermont-Ferrand, France
| | - Rafał J Wiglusz
- International Institute of Translational Medicine, Malin, 55-124, Poland.,Institute of Low Temperature and Structure Research, Polish Academy of Sciences, Okolna 2, 50-422 Wroclaw, Poland
| |
Collapse
|
3
|
Marycz K, Turlej E, Kornicka-Garbowska K, Zachanowicz E, Tomaszewska A, Kulpa-Greszta M, Pązik R. Co 0.5Mn 0.5Fe 2O 4@PMMA Nanoparticles Promotes Preosteoblast Differentiation through Activation of OPN-BGLAP2-DMP1 Axis and Modulates Osteoclastogenesis under Magnetic Field Conditions. MATERIALS 2021; 14:ma14175010. [PMID: 34501099 PMCID: PMC8434396 DOI: 10.3390/ma14175010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/18/2021] [Revised: 08/27/2021] [Accepted: 08/30/2021] [Indexed: 12/13/2022]
Abstract
The prevalence of osteoporosis in recent years is rapidly increasing. For this reason, there is an urgent need to develop bone substitutes and composites able to enhance the regeneration of damaged tissues which meet the patients’ needs. In the case of osteoporosis, personalized, tailored materials should enhance the impaired healing process and restore the balance between osteoblast and osteoclast activity. In this study, we fabricated a novel hybrid material (Co0.5Mn0.5Fe2O4@PMMA) and investigated its properties and potential utility in the treatment of osteoporosis. The material structure was investigated with X-ray diffraction, Fourier-transform infrared spectroscopy with attenuated total reflectance, FTIR-ATR, transmission electron microscopy (TEM), scanning electron microscopy (SEM) and selected area (electron) diffraction (SAED). Then, the biological properties of the material were investigated with pre-osteoblast (MC3T3-E1) and pre-osteoclasts (4B12) and in the presence or absence of magnetic field, using RT-qPCR and RT-PCR. During the studies, we established that the impact of the new hybrids on the pre-osteoblasts and pre-osteoclasts could be modified by the presence of the magnetic field, which could influence on the PMMA covered by magnetic nanoparticles impact on the expression of genes related to the apoptosis, cells differentiation, adhesion, microRNAs or regulating the inflammatory processes in both murine cell lines. In summary, the Co0.5Mn0.5Fe2O4@PMMA hybrid may represent a novel approach for material optimization and may be a way forward in the fabrication of scaffolds with enhanced bioactivity that benefits osteoporotic patients.
Collapse
Affiliation(s)
- Krzysztof Marycz
- Department of Experimental Biology, Wrocław University of Environmental and Life Sciences, ul. CK. Norwida 27B, 50-375 Wrocław, Poland; (E.T.); (K.K.-G.)
- International Institute of Translational Medicine (MIMT), ul. Jesionowa 11, Malin, 55-114 Wisznia Mała, Poland
- Correspondence: ; Tel.: +48-71-320-5201
| | - Eliza Turlej
- Department of Experimental Biology, Wrocław University of Environmental and Life Sciences, ul. CK. Norwida 27B, 50-375 Wrocław, Poland; (E.T.); (K.K.-G.)
| | - Katarzyna Kornicka-Garbowska
- Department of Experimental Biology, Wrocław University of Environmental and Life Sciences, ul. CK. Norwida 27B, 50-375 Wrocław, Poland; (E.T.); (K.K.-G.)
- International Institute of Translational Medicine (MIMT), ul. Jesionowa 11, Malin, 55-114 Wisznia Mała, Poland
| | - Emilia Zachanowicz
- Polymer Engineering and Technology Division, Wroclaw University of Technology, ul. Wyb. Wyspiańskiego 27, 50-370 Wrocław, Poland;
| | - Anna Tomaszewska
- Department of Biotechnology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland; (A.T.); (M.K.-G.); (R.P.)
| | - Magdalena Kulpa-Greszta
- Department of Biotechnology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland; (A.T.); (M.K.-G.); (R.P.)
- Faculty of Chemistry, Rzeszow University of Technology, Aleja Powstańców Warszawy 12, 35-959 Rzeszow, Poland
| | - Robert Pązik
- Department of Biotechnology, Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland; (A.T.); (M.K.-G.); (R.P.)
| |
Collapse
|
4
|
Marycz K, Smieszek A, Marcinkowska K, Sikora M, Turlej E, Sobierajska P, Patej A, Bienko A, Wiglusz RJ. Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast - A Novel Concept for Osteoporosis Treatment: Part 1. Int J Nanomedicine 2021; 16:3429-3456. [PMID: 34040372 PMCID: PMC8140937 DOI: 10.2147/ijn.s303412] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Accepted: 04/13/2021] [Indexed: 12/11/2022] Open
Abstract
Purpose Osteoporosis results in a severe decrease in the life quality of many people worldwide. The latest data shows that the number of osteoporotic fractures is becoming an increasing international health service problem. Therefore, a new kind of controllable treatment methods for osteoporotic fractures is extensively desired. For that reason, we have manufactured and evaluated nanohydroxyapatite (nHAp)-based composite co-doped with iron oxide (IO) nanoparticles. The biomaterial was used as a matrix for the controlled delivery of miR-21-5p and miR-124-3p, which have a proven impact on bone cell metabolism. Methods The nanocomposite Ca5(PO4)3OH/Fe3O4 (later called nHAp/IO) was obtained by the wet chemistry method and functionalised with microRNAs (nHAp/IO@miR-21/124). Its physicochemical characterization was performed using XRPD, FT-IR, SEM-EDS and HRTEM and SAED methods. The modulatory effect of the composite was tested in vitro using murine pre-osteoblasts MC3T3-E1 and pre-osteoclasts 4B12. Moreover, the anti-inflammatory effects of biomaterial were analysed using a model of LPS-treated murine macrophages RAW 264.7. We have analysed the cells’ viability, mitochondria membrane potential and oxidative stress under magnetic field (MF+) and without (MF-). Moreover, the results were supplemented with RT-qPCR and Western blot assays to evaluate the expression profile for master regulators of bone metabolism. Results The results indicated pro-osteogenic effects of nHAp/IO@miR-21/124 composite enhanced by exposure to MF. The enhanced osteogenesis guided by nHAp/IO@miR-21/124 presence was associated with increased metabolism of progenitor cells and activation of osteogenic markers (Runx-2, Opn, Coll-1). Simultaneously, nanocomposite decreased metabolism and differentiation of pre-osteoclastic 4B12 cells accompanied by reduced expression of CaII and Ctsk. Obtained composite regulated viability of bone progenitor cells and showed immunomodulatory properties inhibiting the expression of inflammatory markers, ie, TNF-α, iNOs or IL-1β, in LPS-stimulated RAW 264.7 cells. Conclusion We have described for the first time a new concept of osteoporosis treatment based on nHAp/IO@miR-21/124 application. Obtained results indicated that fabricated nanocomposite might impact proper regeneration of osteoporotic bone, restoring the balance between osteoblasts and osteoclast.
Collapse
Affiliation(s)
- Krzysztof Marycz
- The Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences, Wroclaw, Poland.,International Institute of Translational Medicine, Malin, Poland
| | - Agnieszka Smieszek
- The Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences, Wroclaw, Poland
| | - Klaudia Marcinkowska
- The Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences, Wroclaw, Poland
| | - Mateusz Sikora
- The Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences, Wroclaw, Poland
| | - Eliza Turlej
- The Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences, Wroclaw, Poland
| | | | - Adrian Patej
- Institute of Low Temperature and Structure Research, PAS, Wroclaw, Poland
| | - Alina Bienko
- Faculty of Chemistry, University of Wroclaw, Wroclaw, Poland
| | - Rafal J Wiglusz
- Institute of Low Temperature and Structure Research, PAS, Wroclaw, Poland
| |
Collapse
|
5
|
Marycz K, Sobierajska P, Wiglusz RJ, Idczak R, Nedelec JM, Fal A, Kornicka-Garbowska K. <p>Fe<sub>3</sub>O<sub>4</sub> Magnetic Nanoparticles Under Static Magnetic Field Improve Osteogenesis via RUNX-2 and Inhibit Osteoclastogenesis by the Induction of Apoptosis</p>. Int J Nanomedicine 2020; 15:10127-10148. [PMID: 36213447 PMCID: PMC9537728 DOI: 10.2147/ijn.s256542] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Accepted: 09/08/2020] [Indexed: 12/14/2022] Open
Affiliation(s)
- Krzysztof Marycz
- The Department of Experimental Biology, University of Environmental and Life Sciences Wroclaw, Wroclaw50-375, Poland
- Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, Warsaw01-938, Poland
- International Institute of Translational Medicine, Malin55-114, Poland
- Correspondence: Krzysztof Marycz The Department of Experimental Biology, University of Environmental and Life Sciences Wroclaw, Norwida 27B, Wrocław50-375, PolandTel +48 71 320 5201 Email
| | - Paulina Sobierajska
- Institute of Low Temperature and Structure Research, Polish Academy of Sciences, Wroclaw50-422, Poland
| | - Rafał J Wiglusz
- Institute of Low Temperature and Structure Research, Polish Academy of Sciences, Wroclaw50-422, Poland
| | - Rafał Idczak
- Centre for Advanced Materials and Smart Structures, Polish Academy of Sciences, Wroclaw50-950, Poland
| | - Jean-Marie Nedelec
- CNRS, SIGMA Clermont, ICCF, Université Clermont Auvergne, Clermont-Ferrand, France
| | - Andrzej Fal
- Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, Warsaw01-938, Poland
| | - Katarzyna Kornicka-Garbowska
- The Department of Experimental Biology, University of Environmental and Life Sciences Wroclaw, Wroclaw50-375, Poland
- International Institute of Translational Medicine, Malin55-114, Poland
| |
Collapse
|
6
|
The Role of miR-21 in Osteoblasts-Osteoclasts Coupling In Vitro. Cells 2020; 9:cells9020479. [PMID: 32093031 PMCID: PMC7072787 DOI: 10.3390/cells9020479] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2019] [Revised: 02/17/2020] [Accepted: 02/18/2020] [Indexed: 12/11/2022] Open
Abstract
MiR-21 is being gradually more and more recognized as a molecule regulating bone tissue homeostasis. However, its function is not fully understood due to the dual role of miR-21 on bone-forming and bone-resorbing cells. In this study, we investigated the impact of miR-21 inhibition on pre-osteoblastic cells differentiation and paracrine signaling towards pre-osteoclasts using indirect co-culture model of mouse pre-osteoblast (MC3T3) and pre-osteoclast (4B12) cell lines. The inhibition of miR-21 in MC3T3 cells (MC3T3inh21) modulated expression of genes encoding osteogenic markers including collagen type I (Coll-1), osteocalcin (Ocl), osteopontin (Opn), and runt-related transcription factor 2 (Runx-2). Inhibition of miR-21 in osteogenic cultures of MC3T3 also inflected the synthesis of OPN protein which is essential for proper mineralization of extracellular matrix (ECM) and anchoring osteoclasts to the bones. Furthermore, it was shown that in osteoblasts miR-21 regulates expression of factors that are vital for survival of pre-osteoclast, such as receptor activator of nuclear factor κB ligand (RANKL). The pre-osteoclast cultured with MC3T3inh21 cells was characterized by lowered expression of several markers associated with osteoclasts' differentiation, foremost tartrate-resistant acid phosphatase (Trap) but also receptor activator of nuclear factor-κB ligand (Rank), cathepsin K (Ctsk), carbonic anhydrase II (CaII), and matrix metalloproteinase (Mmp-9). Collectively, our data indicate that the inhibition of miR-21 in MC3T3 cells impairs the differentiation and ECM mineralization as well as influences paracrine signaling leading to decreased viability of pre-osteoclasts.
Collapse
|
7
|
Marycz K, Sobierajska P, Roecken M, Kornicka-Garbowska K, Kępska M, Idczak R, Nedelec JM, Wiglusz RJ. Iron oxides nanoparticles (IOs) exposed to magnetic field promote expression of osteogenic markers in osteoblasts through integrin alpha-3 (INTa-3) activation, inhibits osteoclasts activity and exerts anti-inflammatory action. J Nanobiotechnology 2020; 18:33. [PMID: 32070362 PMCID: PMC7027282 DOI: 10.1186/s12951-020-00590-w] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2019] [Accepted: 02/02/2020] [Indexed: 12/19/2022] Open
Abstract
Background Prevalence of osteoporosis is rapidly growing and so searching for novel therapeutics. Yet, there is no drug on the market available to modulate osteoclasts and osteoblasts activity simultaneously. Thus in presented research we decided to fabricate nanocomposite able to: (i) enhance osteogenic differentiation of osteoblast, (i) reduce osteoclasts activity and (iii) reduce pro-inflammatory microenvironment. As a consequence we expect that fabricated material will be able to inhibit bone loss during osteoporosis. Results The α-Fe2O3/γ-Fe2O3 nanocomposite (IOs) was prepared using the modified sol–gel method. The structural properties, size, morphology and Zeta-potential of the particles were studied by means of XRPD (X-ray powder diffraction), SEM (Scanning Electron Microscopy), PALS and DLS techniques. The identification of both phases was checked by the use of Raman spectroscopy and Mössbauer measurement. Moreover, the magnetic properties of the obtained IOs nanoparticles were determined. Then biological properties of material were investigated with osteoblast (MC3T3), osteoclasts (4B12) and macrophages (RAW 264.7) in the presence or absence of magnetic field, using confocal microscope, RT-qPCR, western blot and cell analyser. Here we have found that fabricated IOs: (i) do not elicit immune response; (ii) reduce inflammation; (iii) enhance osteogenic differentiation of osteoblasts; (iv) modulates integrin expression and (v) triggers apoptosis of osteoclasts. Conclusion Fabricated by our group α-Fe2O3/γ-Fe2O3 nanocomposite may become an justified and effective therapeutic intervention during osteoporosis treatment.
Collapse
Affiliation(s)
- K Marycz
- The Department of Experimental Biology, University of Environmental and Life Sciences Wroclaw, Norwida 27B, 50-375, Wrocław, Poland. .,Faculty of Veterinary Medicine, Equine Clinic-Equine Surgery, Justus-Liebig-University, Frankfurter 108, 35392, Giessen, Lahn, Germany. .,International Institute of Translational Medicine, Jesionowa 11, Malin, 55-114, Wisznia Mała, Poland.
| | - P Sobierajska
- Institute of Low Temperature and Structure Research, Polish Academy of Sciences, Okolna 2, 50-422, Wrocław, Poland
| | - M Roecken
- Faculty of Veterinary Medicine, Equine Clinic-Equine Surgery, Justus-Liebig-University, Frankfurter 108, 35392, Giessen, Lahn, Germany
| | - K Kornicka-Garbowska
- The Department of Experimental Biology, University of Environmental and Life Sciences Wroclaw, Norwida 27B, 50-375, Wrocław, Poland.,International Institute of Translational Medicine, Jesionowa 11, Malin, 55-114, Wisznia Mała, Poland
| | - M Kępska
- The Department of Experimental Biology, University of Environmental and Life Sciences Wroclaw, Norwida 27B, 50-375, Wrocław, Poland
| | - R Idczak
- Institute of Low Temperature and Structure Research, Polish Academy of Sciences, Okolna 2, 50-422, Wrocław, Poland
| | - J-M Nedelec
- Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, Clermont-Ferrand, France
| | - R J Wiglusz
- Institute of Low Temperature and Structure Research, Polish Academy of Sciences, Okolna 2, 50-422, Wrocław, Poland.,Centre for Advanced Materials and Smart Structures, Polish Academy of Sciences, Okolna 2, 50-950, Wrocław, Poland
| |
Collapse
|
8
|
Sambamurthy N, Zhou C, Nguyen V, Smalley R, Hankenson KD, Dodge GR, Scanzello CR. Deficiency of the pattern-recognition receptor CD14 protects against joint pathology and functional decline in a murine model of osteoarthritis. PLoS One 2018; 13:e0206217. [PMID: 30485272 PMCID: PMC6261538 DOI: 10.1371/journal.pone.0206217] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2018] [Accepted: 10/09/2018] [Indexed: 12/18/2022] Open
Abstract
Objective CD14 is a monocyte/macrophage pattern-recognition receptor that modulates innate inflammatory signaling. Soluble CD14 levels in knee OA synovial fluids are associated with symptoms and progression of disease. Here we investigate the role of this receptor in development of OA using a murine joint injury model of disease. Methods 10-week-old Male C57BL/6 (WT) and CD14-deficient (CD14-/-) mice underwent destabilization of the medial meniscus (DMM) surgery to induce OA. Joint histopathology was used to examine cartilage damage, and microCT to evaluate subchondral bone (SCB) remodeling at 6 and 19 weeks after surgery. Synovial and fat pad expression of macrophage markers (F4/80, CD11c, CD68, iNOS, CCR7, CD163 and CD206) was assessed by flow cytometry and droplet digital (dd)PCR. Changes in locomotive activity indicative of joint pain were evaluated longitudinally up to 16 weeks by automated behavioral analysis. Results Early cartilage damage scores 6 weeks post-DMM were similar in both strains (Mean score ±SEM WT: 4.667±1.38, CD14-/-: 4.6±0.6), but at 19 weeks were less severe in CD14-/- (6.0±0.46) than in WT mice (13.44±2.5, p = 0.0002). CD14-/- mice were protected from both age-related and post-surgical changes in SCB mineral density and trabecular thickness. In addition, CD14-/- mice were protected from decreases in climbing activity (p = 0.015 vs. WT, 8 weeks) observed after DMM. Changes in synovial/fat pad expression of CCR7, a marker of M1 macrophages, were slightly reduced post-DMM in the absence of CD14, while expression of CD68 (pan-macrophage marker) and CD163 (M2 marker) were unchanged. Conclusion CD14 plays an important role in progression of structural and functional features of OA in the DMM model, and may provide a new target for therapeutic development.
Collapse
Affiliation(s)
- Nisha Sambamurthy
- Translational Musculoskeletal Research Center, Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania, United States of America
- University of Pennsylvania Perelman School of Medicine, Division of Rheumatology, Philadelphia, Pennsylvania, United States of America
| | - Cheng Zhou
- Translational Musculoskeletal Research Center, Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania, United States of America
- University of Pennsylvania Perelman School of Medicine, Division of Rheumatology, Philadelphia, Pennsylvania, United States of America
| | - Vu Nguyen
- Translational Musculoskeletal Research Center, Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania, United States of America
- University of Pennsylvania Perelman School of Medicine, Division of Rheumatology, Philadelphia, Pennsylvania, United States of America
| | - Ryan Smalley
- Translational Musculoskeletal Research Center, Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania, United States of America
- University of Pennsylvania Perelman School of Medicine, Department of Orthopedic Surgery, Philadelphia, Pennsylvania, United States of America
| | - Kurt D. Hankenson
- Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan, United States of America
| | - George R. Dodge
- Translational Musculoskeletal Research Center, Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania, United States of America
- University of Pennsylvania Perelman School of Medicine, Department of Orthopedic Surgery, Philadelphia, Pennsylvania, United States of America
| | - Carla R. Scanzello
- Translational Musculoskeletal Research Center, Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania, United States of America
- University of Pennsylvania Perelman School of Medicine, Division of Rheumatology, Philadelphia, Pennsylvania, United States of America
- * E-mail: ,
| |
Collapse
|
9
|
Amano S, Chang YT, Fukui Y. ERK5 activation is essential for osteoclast differentiation. PLoS One 2015; 10:e0125054. [PMID: 25885811 PMCID: PMC4401765 DOI: 10.1371/journal.pone.0125054] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2014] [Accepted: 03/17/2015] [Indexed: 11/30/2022] Open
Abstract
The MEK/ERK pathways are critical for controlling cell proliferation and differentiation. In this study, we show that the MEK5/ERK5 pathway participates in osteoclast differentiation. ERK5 was activated by M-CSF, which is one of the essential factors in osteoclast differentiation. Inhibition of MEK5 by BIX02189 or inhibition of ERK5 by XMD 8-92 blocked osteoclast differentiation. MEK5 knockdown inhibited osteoclast differentiation. RAW264.7D clone cells, which are monocytic cells, differentiate into osteoclasts after stimulation with sRANKL. ERK5 was activated without any stimulation in these cells. Inhibition of the MEK5/ERK5 pathway by the inhibitors also blocked the differentiation of RAW264.7D cells into osteoclasts. Moreover, expression of the transcription factor c-Fos, which is indispensable for osteoclast differentiation, was inhibited by treatment with MEK5 or ERK5 inhibitors. Therefore, activation of ERK5 is required for the induction of c-Fos. These events were confirmed in experiments using M-CSF-dependent bone marrow macrophages. Taken together, the present results show that activation of the MEK5/ERK5 pathway with M-CSF is required for osteoclast differentiation, which may induce differentiation through the induction of c-Fos.
Collapse
Affiliation(s)
- Shigeru Amano
- Division of Microbiology and Immunology, Department of Oral Biology and Tissue Engineering, Meikai University School of Dentistry, Keyakidai, Sakado City, Japan
| | - Yu-Tzu Chang
- National Health Research Institutes, Zhunan town, Miaoli County, Taiwan, Republic of China
| | - Yasuhisa Fukui
- National Health Research Institutes, Zhunan town, Miaoli County, Taiwan, Republic of China
- * E-mail:
| |
Collapse
|
10
|
Montazerolghaem M, Karlsson Ott M, Engqvist H, Melhus H, Rasmusson AJ. Resorption of monetite calcium phosphate cement by mouse bone marrow derived osteoclasts. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2015; 52:212-8. [PMID: 25953560 DOI: 10.1016/j.msec.2015.03.038] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/25/2014] [Revised: 02/10/2015] [Accepted: 03/22/2015] [Indexed: 10/23/2022]
Abstract
Recently the interest for monetite based biomaterials as bone grafts has increased; since in vivo studies have demonstrated that they are degradable, osteoconductive and improve bone healing. So far osteoclastic resorption of monetite has received little attention. The current study focuses on the osteoclastic resorption of monetite cement using primary mouse bone marrow macrophages, which have the potential to differentiate into resorbing osteoclasts when treated with receptor activator NF-κB ligand (RANKL). The osteoclast viability and differentiation were analysed on monetite cement and compared to cortical bovine bone discs. After seven days live/dead stain results showed no significant difference in viability between the two materials. However, the differentiation was significantly higher on the bone discs, as shown by tartrate resistant acid phosphatase (TRAP) activity and Cathepsin K gene expression. Moreover monetite samples with differentiated osteoclasts had a 1.4 fold elevated calcium ion concentration in their culture media compared to monetite samples with undifferentiated cells. This indicates active resorption of monetite in the presence of osteoclasts. In conclusion, this study suggests that osteoclasts have a crucial role in the resorption of monetite based biomaterials. It also provides a useful model for studying in vitro resorption of acidic calcium phosphate cements by primary murine cells.
Collapse
Affiliation(s)
- M Montazerolghaem
- Department of Engineering Sciences, Division of Applied Materials Science, Uppsala University, 751 21 Uppsala, Sweden.
| | - M Karlsson Ott
- Department of Engineering Sciences, Division of Applied Materials Science, Uppsala University, 751 21 Uppsala, Sweden
| | - H Engqvist
- Department of Engineering Sciences, Division of Applied Materials Science, Uppsala University, 751 21 Uppsala, Sweden
| | - H Melhus
- Department of Medical Sciences, Section of Clinical Pharmacology and Osteoporosis, Uppsala University, Uppsala, 751 85 Uppsala, Sweden
| | - A J Rasmusson
- Department of Medical Sciences, Section of Clinical Pharmacology and Osteoporosis, Uppsala University, Uppsala, 751 85 Uppsala, Sweden
| |
Collapse
|